BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

138 related articles for article (PubMed ID: 4819349)

  • 21. Influence of 2-Br-alpha-ergocryptine on serum levels of prolactin and the estrous cycle in sheep.
    Niswender GD
    Endocrinology; 1974 Feb; 94(2):612-5. PubMed ID: 4855722
    [No Abstract]   [Full Text] [Related]  

  • 22. Galactorrhoea: successful treatment with reduction of plasma prolactin levels by brom-ergocryptine.
    Besser GM; Parke L; Edwards CR; Forsyth IA; McNeilly AS
    Br Med J; 1972 Sep; 3(5828):669-72. PubMed ID: 4675488
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Inhibition of cyclic gonadotropin secretion by endogenous human prolactin.
    Tyson JE; Khojandi M; Huth J; Smith B; Thomas P
    Am J Obstet Gynecol; 1975 Feb; 121(3):375-9. PubMed ID: 1115151
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Inhibition of DMBA-induced mammary carcinogenesis in the rat by 2-br- -ergocryptine (CB 154), an inhibitor of prolactin secretion, and by nafoxidine (U-11, 100 A), an estrogen antagonist.
    Heuson JC; Waelbroeck C; Legros N; Gallez G; Robyn C; L'Hermite M
    Gynecol Invest; 1971; 2(1):130-7. PubMed ID: 5170652
    [No Abstract]   [Full Text] [Related]  

  • 25. [2-Br-alpha-ergokryptin: influence on fertility and lactation in the rat].
    Flückiger E; Wagner HR
    Experientia; 1968 Nov; 24(11):1130-1. PubMed ID: 5752992
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Effect of 2-bromo- -ergocryptine on milk yield and the level of prolactin and growth hormone in the blood of the goat at milking.
    Hart IC
    J Endocrinol; 1973 Apr; 57(1):179-80. PubMed ID: 4735631
    [No Abstract]   [Full Text] [Related]  

  • 27. [Effect of 2-Br-alpha-ergocryptine (CB 154) on the secretion of prolactin in Anguilla].
    Olivereau M; Lemoine AM
    C R Acad Hebd Seances Acad Sci D; 1973 Mar; 276(12):1883-6. PubMed ID: 4201536
    [No Abstract]   [Full Text] [Related]  

  • 28. Proceedings: Studies on subcellular zinc distribution in relation to hormone levels in rat prostatic tissue using the electron microscope microanalyser, EMMA.
    Chandler JA; Harper ME; Griffiths K
    J Endocrinol; 1974 May; 61(2):LV-LVI. PubMed ID: 4835921
    [No Abstract]   [Full Text] [Related]  

  • 29. [Inhibition of lactation with 2 Br-alpha-ergocryptine].
    Jaszmann L; Szabó E; Szontágh F
    Orv Hetil; 1974 Sep; 115(35):2053-4. PubMed ID: 4603634
    [No Abstract]   [Full Text] [Related]  

  • 30. Effects of 2-Br-alpha-Ergocryptine, L-dopa and cyclic imides on serum prolactin in postmenopausal women.
    Rozencweig M; Heuson JC; Bila S; L'Hermite M; Robyn C
    Eur J Cancer (1965); 1973 Sep; 9(9):657-64. PubMed ID: 4803232
    [No Abstract]   [Full Text] [Related]  

  • 31. Treatment of galactorrhea-amenorrhea syndrome with Br-ergocryptine (CB 154): restoration of ovulatory function and fertility.
    Varga L; Wenner R; Del Pozo E
    Am J Obstet Gynecol; 1973 Sep; 117(1):75-9. PubMed ID: 4722381
    [No Abstract]   [Full Text] [Related]  

  • 32. Possible rôle of prolactin during the oestrous cycle and gestation in the ewe.
    Kann G; Denamur R
    J Reprod Fertil; 1974 Aug; 39(2):473-83. PubMed ID: 4415140
    [No Abstract]   [Full Text] [Related]  

  • 33. [Analogue drugs of ergot-alkaloids with an inhibitory effect upon prolactin secretion and their influence upon the mammary gland (author's transl)].
    Rezábek K; Ausková M; Semonský M
    Cesk Gynekol; 1975 Feb; 40(1):52-3. PubMed ID: 1131904
    [No Abstract]   [Full Text] [Related]  

  • 34. Effect of inhibiting the lactogenic signal at calving on milk production and metabolic and immune perturbations in dairy cows.
    Vanacker N; Ollier S; Beaudoin F; Blouin R; Lacasse P
    J Dairy Sci; 2017 Jul; 100(7):5782-5791. PubMed ID: 28501406
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Inhibition of thyrotropin and prolactin secretions in primary hypothyroidism by 2-Br-alpha-ergocryptine.
    Miyal K; Onishi T; Hosokawa M; Ishibashi K; Kumahara Y
    J Clin Endocrinol Metab; 1974 Aug; 39(2):391-4. PubMed ID: 4418165
    [No Abstract]   [Full Text] [Related]  

  • 36. Inhibition by apomorphine of prolactin secretion in patients with elevated serum prolactin.
    Martin JB; Lal S; Tolis G; Friesen HG
    J Clin Endocrinol Metab; 1974 Jul; 39(1):180-2. PubMed ID: 4835131
    [No Abstract]   [Full Text] [Related]  

  • 37. Endocrine profile of a specific prolactin inhibitor: Br-ergocryptine (CB 154). A preliminary report.
    Del Pozo E; Friesen H; Burmeister P
    Schweiz Med Wochenschr; 1973 Jun; 103(23):847-8. PubMed ID: 4351250
    [No Abstract]   [Full Text] [Related]  

  • 38. Secretion and mammary gland uptake of prolactin in dairy cows during lactogenesis.
    Malven PV; Head HH; Collier RJ
    J Dairy Sci; 1987 Nov; 70(11):2241-53. PubMed ID: 3693630
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Reduction of serum prolactin in rats by 2 ergot alkaloids and 2 ergoline derivatives: a comparison.
    Brooks CL; Welsch CW
    Proc Soc Exp Biol Med; 1974 Jul; 146(3):863-7. PubMed ID: 4841203
    [No Abstract]   [Full Text] [Related]  

  • 40. Influence of nursing on the release of prolactin and GH in mice with high and low incidence of mammary tumors.
    Sinha YN; Salocks CB; Lewis UJ; VanderLaan WP
    Endocrinology; 1974 Oct; 95(4):947-54. PubMed ID: 4472149
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.